Honasa Consumer Ltd Share Price – NSE /  BSE

Trading, Small Cap

Honasa Consumer has allotted 3,59,604 equity shares under ESOP on 06 March 2025. With this allotment, the paid up equity share capital has increased to Rs. 325,18,36,100/- consisting of 32,51,83,610 equity shares of face value of Rs. 10/- (Rupees Ten) each.

Powered by Capital Market - Live News

Revenue from operations rose 6% to Rs 517.51 crore in Q3 FY25 as compared with Rs 488.21 crore posted in corresponding quarter last year.

As part of Project 'Neev', the holding company has discontinued the super stockist layer and certain direct distributors, replacing them with higher-quality Tier 1 distributors to service retailers across the top 50 cities. Following this transition, as of December 31, 2024, the company has outstanding provisions for sales returns amounting to Rs 8.95 crore, with a resulting right-to-return asset of Rs 1.09 crore.

EBITDA stood at Rs 26 crore, recording de-growth of 23.53% as compared with Rs 34 crore in Q3 FY24. EBITDA margin stood at 5% in Q3 FY25 as against 7.1% in Q3 FY24.

According to NielsenIQ, Mamaearth grew in market share and household penetration. The brand reached 2,16,814 FMCG retail outlets in India as of Dec’24, increasing distribution by 22% YoY, Mamaearth face wash gained +114 bps and shampoo gained +20bps in value market share YoY, reflecting strong brand equity.

Varun Alagh, Chairman and CEO & Co-founder, Honasa Consumer, said, “In Q3FY25, we remained committed to long-term growth, advancing the strategic implementation of Project Neev to strengthen our offline distribution through direct distributors in the top 50 cities. With continuous progress in this journey, our revenue for Q3FY25 stood at Rs 518 crore with 6.0% YoY growth and an EBITDA margin of 5.0%

Mamaearth continued to expand its market share and household penetration as we refine our playbooks to shape its future growth trajectory. Our emerging brands - The Derma Co., Aqualogica, BBlunt, and Dr. Sheth’s - delivered 30%+ YTD YoY growth. Additionally, our key categories (face wash, shampoo, serums, moisturizer, sun care, and baby care) saw ~18% growth in 9MFY25. We are continuing to build in these categories and aim to gain significant share in the next 3-5 year

Honasa Consumer is the largest digital-first beauty and personal care company with a diverse portfolio of six brands. Uniquely positioned to capture the growth trends shaping in the BPC market, the company is building brands through on trend data-based innovation and strong omnichannel distribution.

Powered by Capital Market - Live News

The key equity indices traded with substantial gains in the morning trade as inflation eased to a five-month low, according to data released by the government. The Nifty traded above the 23,150 mark after hitting the day's low of 22,992.20 in early trade. Pharma shares advanced after declining over the past three consecutive trading sessions. Trading could be volatile due to the weekly Nifty 50 F&O series expiry today.

At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 350.96 points or 0.46% to 76,519.26. The Nifty 50 index added 110.35 points or 0.48% to 23,155.60.

In the broader market, The S&P BSE Mid-Cap index rallied 1.10%, and the S&P BSE Small-Cap index declined 0.73%.

The market breadth was positive. On the BSE, 2,395 shares rose and 1,118 shares fell. A total of 158 shares were unchanged.

Economy:

India’s retail inflation, based on the Consumer Price Index (CPI), eased to a five-month low of 4.31% in January 2025, mainly due to lower food prices, according to official data released on Wednesday. CPI-based retail inflation was 5.22% in December, and 5.1% in January 2024.

India’s industrial production growth, measured by the Index of Industrial Production (IIP) eased to 3.2% in December, down from a 6-month high of 5.2% in the previous month, according to data released by Ministry of Statistics & Programme Implementation (MoSPI). The slowdown was largely due to weaker manufacturing activity, which grew 3% in December compared to 5.5% in November.

Result Today:

Afcons Infrastructure (down 0.84%), Allcargo Logistics (up 1.17%), Anupam Rasayan India (down 0.35%), BF Utilities (up 2.78%), Capacite Infraprojects (up 1.94%), Carborundum Universal (down 0.16%), Concord Biotech (up 2.36%), DCW (up 1.66%), Deepak Nitrite (up 1.50%), Godfrey Phillips India (down 2.58%), Goodyear India (down 2.18%), Gujarat Pipavav Port (up 0.84%), Grindwell Norton (down 0.43%), Harsha Engineers International (up 0.89%), Hindustan Construction Co (down 1.65%), HealthCare Global Enterprises (down 0.85%), Hindalco Industries (up 0.44%), IPCA Laboratories (up 2.46%), India Tourism Development (down 0.29%) will declare their results later today.

Buzzing Index:

The Nifty Pharma index jumped 1.97% to 21,558.95. The index dropped 4.23% in past three consecutive trading sessions.

Aurobindo Pharma (up 5.01%), Lupin (up 4.82%), Granules India (up 3.76%), Mankind Pharma (up 3.23%), Biocon (up 3.22%), Cipla (up 2.83%), Divis Laboratories (up 2.78%), Laurus Labs (up 2.65%), Ipca Laboratories (up 2.12%) and Glenmark Pharmaceuticals (up 1.91%) advanced.

Stocks in Spotlight:

Honasa Consumer jumped 5.01% after the company’s consolidated net profit increased marginally to Rs 26.02 crore in Q3 FY25, up 0.5% as compared with Rs 25.90 crore in Q3 FY24. Net sales rose 6% to Rs 571.51 crore in Q3 FY25 as compared with Rs 488.22 crore in Q3 FY24.

Jupiter Wagons (JWL) rose 1.31% after the company said that it has received order from Ambuja Cement and ACC for manufacture and supply of BCFCM rakes wagon and the value of these orders is Rs 600 crore.

Rites added 1.10% after the company said that it has signed a memorandum of understanding (MoU) with a Centre for Development of Advanced Computing (C-DAC) to collaborate on IT solutions for consultancy assignments.

Powered by Capital Market - Live News

Revenue from operations rose 6% to Rs 517.51 crore in Q3 FY25 as compared with Rs 488.21 crore posted in corresponding quarter last year.

As part of Project 'Neev', the holding company has discontinued the super stockist layer and certain direct distributors, replacing them with higher-quality Tier 1 distributors to service retailers across the top 50 cities. Following this transition, as of December 31, 2024, the company has outstanding provisions for sales returns amounting to Rs 8.95 crore, with a resulting right-to-return asset of Rs 1.09 crore.

EBITDA stood at Rs 26 crore, recording de-growth of 23.53% as compared with Rs 34 crore in Q3 FY24. EBITDA margin stood at 5% in Q3 FY25 as against 7.1% in Q3 FY24.

According to NielsenIQ, Mamaearth grew in market share and household penetration. The brand reached 2,16,814 FMCG retail outlets in India as of Dec’24, increasing distribution by 22% YoY, Mamaearth face wash gained +114 bps and shampoo gained +20bps in value market share YoY, reflecting strong brand equity.

Varun Alagh, Chairman and CEO & Co-founder, Honasa Consumer, said, “In Q3FY25, we remained committed to long-term growth, advancing the strategic implementation of Project Neev to strengthen our offline distribution through direct distributors in the top 50 cities. With continuous progress in this journey, our revenue for Q3FY25 stood at Rs 518 crore with 6.0% YoY growth and an EBITDA margin of 5.0%

Mamaearth continued to expand its market share and household penetration as we refine our playbooks to shape its future growth trajectory. Our emerging brands - The Derma Co., Aqualogica, BBlunt, and Dr. Sheth’s - delivered 30%+ YTD YoY growth. Additionally, our key categories (face wash, shampoo, serums, moisturizer, sun care, and baby care) saw ~18% growth in 9MFY25. We are continuing to build in these categories and aim to gain significant share in the next 3-5 year

Honasa Consumer is the largest digital-first beauty and personal care company with a diverse portfolio of six brands. Uniquely positioned to capture the growth trends shaping in the BPC market, the company is building brands through on trend data-based innovation and strong omnichannel distribution.

Powered by Capital Market - Live News

The key equity indices traded with substantial gains in the morning trade as inflation eased to a five-month low, according to data released by the government. The Nifty traded above the 23,150 mark after hitting the day's low of 22,992.20 in early trade. Pharma shares advanced after declining over the past three consecutive trading sessions. Trading could be volatile due to the weekly Nifty 50 F&O series expiry today.

At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 350.96 points or 0.46% to 76,519.26. The Nifty 50 index added 110.35 points or 0.48% to 23,155.60.

In the broader market, The S&P BSE Mid-Cap index rallied 1.10%, and the S&P BSE Small-Cap index declined 0.73%.

The market breadth was positive. On the BSE, 2,395 shares rose and 1,118 shares fell. A total of 158 shares were unchanged.

Economy:

India’s retail inflation, based on the Consumer Price Index (CPI), eased to a five-month low of 4.31% in January 2025, mainly due to lower food prices, according to official data released on Wednesday. CPI-based retail inflation was 5.22% in December, and 5.1% in January 2024.

India’s industrial production growth, measured by the Index of Industrial Production (IIP) eased to 3.2% in December, down from a 6-month high of 5.2% in the previous month, according to data released by Ministry of Statistics & Programme Implementation (MoSPI). The slowdown was largely due to weaker manufacturing activity, which grew 3% in December compared to 5.5% in November.

Result Today:

Afcons Infrastructure (down 0.84%), Allcargo Logistics (up 1.17%), Anupam Rasayan India (down 0.35%), BF Utilities (up 2.78%), Capacite Infraprojects (up 1.94%), Carborundum Universal (down 0.16%), Concord Biotech (up 2.36%), DCW (up 1.66%), Deepak Nitrite (up 1.50%), Godfrey Phillips India (down 2.58%), Goodyear India (down 2.18%), Gujarat Pipavav Port (up 0.84%), Grindwell Norton (down 0.43%), Harsha Engineers International (up 0.89%), Hindustan Construction Co (down 1.65%), HealthCare Global Enterprises (down 0.85%), Hindalco Industries (up 0.44%), IPCA Laboratories (up 2.46%), India Tourism Development (down 0.29%) will declare their results later today.

Buzzing Index:

The Nifty Pharma index jumped 1.97% to 21,558.95. The index dropped 4.23% in past three consecutive trading sessions.

Aurobindo Pharma (up 5.01%), Lupin (up 4.82%), Granules India (up 3.76%), Mankind Pharma (up 3.23%), Biocon (up 3.22%), Cipla (up 2.83%), Divis Laboratories (up 2.78%), Laurus Labs (up 2.65%), Ipca Laboratories (up 2.12%) and Glenmark Pharmaceuticals (up 1.91%) advanced.

Stocks in Spotlight:

Honasa Consumer jumped 5.01% after the company’s consolidated net profit increased marginally to Rs 26.02 crore in Q3 FY25, up 0.5% as compared with Rs 25.90 crore in Q3 FY24. Net sales rose 6% to Rs 571.51 crore in Q3 FY25 as compared with Rs 488.22 crore in Q3 FY24.

Jupiter Wagons (JWL) rose 1.31% after the company said that it has received order from Ambuja Cement and ACC for manufacture and supply of BCFCM rakes wagon and the value of these orders is Rs 600 crore.

Rites added 1.10% after the company said that it has signed a memorandum of understanding (MoU) with a Centre for Development of Advanced Computing (C-DAC) to collaborate on IT solutions for consultancy assignments.

Powered by Capital Market - Live News

Net profit of Honasa Consumer rose 0.46% to Rs 26.02 crore in the quarter ended December 2024 as against Rs 25.90 crore during the previous quarter ended December 2023. Sales rose 6.00% to Rs 517.51 crore in the quarter ended December 2024 as against Rs 488.22 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Honasa Consumer has allotted 3,59,604 equity shares under ESOP on 06 March 2025. With this allotment, the paid up equity share capital has increased to Rs. 325,18,36,100/- consisting of 32,51,83,610 equity shares of face value of Rs. 10/- (Rupees Ten) each.

Powered by Capital Market - Live News

Revenue from operations rose 6% to Rs 517.51 crore in Q3 FY25 as compared with Rs 488.21 crore posted in corresponding quarter last year.

As part of Project 'Neev', the holding company has discontinued the super stockist layer and certain direct distributors, replacing them with higher-quality Tier 1 distributors to service retailers across the top 50 cities. Following this transition, as of December 31, 2024, the company has outstanding provisions for sales returns amounting to Rs 8.95 crore, with a resulting right-to-return asset of Rs 1.09 crore.

EBITDA stood at Rs 26 crore, recording de-growth of 23.53% as compared with Rs 34 crore in Q3 FY24. EBITDA margin stood at 5% in Q3 FY25 as against 7.1% in Q3 FY24.

According to NielsenIQ, Mamaearth grew in market share and household penetration. The brand reached 2,16,814 FMCG retail outlets in India as of Dec’24, increasing distribution by 22% YoY, Mamaearth face wash gained +114 bps and shampoo gained +20bps in value market share YoY, reflecting strong brand equity.

Varun Alagh, Chairman and CEO & Co-founder, Honasa Consumer, said, “In Q3FY25, we remained committed to long-term growth, advancing the strategic implementation of Project Neev to strengthen our offline distribution through direct distributors in the top 50 cities. With continuous progress in this journey, our revenue for Q3FY25 stood at Rs 518 crore with 6.0% YoY growth and an EBITDA margin of 5.0%

Mamaearth continued to expand its market share and household penetration as we refine our playbooks to shape its future growth trajectory. Our emerging brands - The Derma Co., Aqualogica, BBlunt, and Dr. Sheth’s - delivered 30%+ YTD YoY growth. Additionally, our key categories (face wash, shampoo, serums, moisturizer, sun care, and baby care) saw ~18% growth in 9MFY25. We are continuing to build in these categories and aim to gain significant share in the next 3-5 year

Honasa Consumer is the largest digital-first beauty and personal care company with a diverse portfolio of six brands. Uniquely positioned to capture the growth trends shaping in the BPC market, the company is building brands through on trend data-based innovation and strong omnichannel distribution.

Powered by Capital Market - Live News

The key equity indices traded with substantial gains in the morning trade as inflation eased to a five-month low, according to data released by the government. The Nifty traded above the 23,150 mark after hitting the day's low of 22,992.20 in early trade. Pharma shares advanced after declining over the past three consecutive trading sessions. Trading could be volatile due to the weekly Nifty 50 F&O series expiry today.

At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 350.96 points or 0.46% to 76,519.26. The Nifty 50 index added 110.35 points or 0.48% to 23,155.60.

In the broader market, The S&P BSE Mid-Cap index rallied 1.10%, and the S&P BSE Small-Cap index declined 0.73%.

The market breadth was positive. On the BSE, 2,395 shares rose and 1,118 shares fell. A total of 158 shares were unchanged.

Economy:

India’s retail inflation, based on the Consumer Price Index (CPI), eased to a five-month low of 4.31% in January 2025, mainly due to lower food prices, according to official data released on Wednesday. CPI-based retail inflation was 5.22% in December, and 5.1% in January 2024.

India’s industrial production growth, measured by the Index of Industrial Production (IIP) eased to 3.2% in December, down from a 6-month high of 5.2% in the previous month, according to data released by Ministry of Statistics & Programme Implementation (MoSPI). The slowdown was largely due to weaker manufacturing activity, which grew 3% in December compared to 5.5% in November.

Result Today:

Afcons Infrastructure (down 0.84%), Allcargo Logistics (up 1.17%), Anupam Rasayan India (down 0.35%), BF Utilities (up 2.78%), Capacite Infraprojects (up 1.94%), Carborundum Universal (down 0.16%), Concord Biotech (up 2.36%), DCW (up 1.66%), Deepak Nitrite (up 1.50%), Godfrey Phillips India (down 2.58%), Goodyear India (down 2.18%), Gujarat Pipavav Port (up 0.84%), Grindwell Norton (down 0.43%), Harsha Engineers International (up 0.89%), Hindustan Construction Co (down 1.65%), HealthCare Global Enterprises (down 0.85%), Hindalco Industries (up 0.44%), IPCA Laboratories (up 2.46%), India Tourism Development (down 0.29%) will declare their results later today.

Buzzing Index:

The Nifty Pharma index jumped 1.97% to 21,558.95. The index dropped 4.23% in past three consecutive trading sessions.

Aurobindo Pharma (up 5.01%), Lupin (up 4.82%), Granules India (up 3.76%), Mankind Pharma (up 3.23%), Biocon (up 3.22%), Cipla (up 2.83%), Divis Laboratories (up 2.78%), Laurus Labs (up 2.65%), Ipca Laboratories (up 2.12%) and Glenmark Pharmaceuticals (up 1.91%) advanced.

Stocks in Spotlight:

Honasa Consumer jumped 5.01% after the company’s consolidated net profit increased marginally to Rs 26.02 crore in Q3 FY25, up 0.5% as compared with Rs 25.90 crore in Q3 FY24. Net sales rose 6% to Rs 571.51 crore in Q3 FY25 as compared with Rs 488.22 crore in Q3 FY24.

Jupiter Wagons (JWL) rose 1.31% after the company said that it has received order from Ambuja Cement and ACC for manufacture and supply of BCFCM rakes wagon and the value of these orders is Rs 600 crore.

Rites added 1.10% after the company said that it has signed a memorandum of understanding (MoU) with a Centre for Development of Advanced Computing (C-DAC) to collaborate on IT solutions for consultancy assignments.

Powered by Capital Market - Live News

Revenue from operations rose 6% to Rs 517.51 crore in Q3 FY25 as compared with Rs 488.21 crore posted in corresponding quarter last year.

As part of Project 'Neev', the holding company has discontinued the super stockist layer and certain direct distributors, replacing them with higher-quality Tier 1 distributors to service retailers across the top 50 cities. Following this transition, as of December 31, 2024, the company has outstanding provisions for sales returns amounting to Rs 8.95 crore, with a resulting right-to-return asset of Rs 1.09 crore.

EBITDA stood at Rs 26 crore, recording de-growth of 23.53% as compared with Rs 34 crore in Q3 FY24. EBITDA margin stood at 5% in Q3 FY25 as against 7.1% in Q3 FY24.

According to NielsenIQ, Mamaearth grew in market share and household penetration. The brand reached 2,16,814 FMCG retail outlets in India as of Dec’24, increasing distribution by 22% YoY, Mamaearth face wash gained +114 bps and shampoo gained +20bps in value market share YoY, reflecting strong brand equity.

Varun Alagh, Chairman and CEO & Co-founder, Honasa Consumer, said, “In Q3FY25, we remained committed to long-term growth, advancing the strategic implementation of Project Neev to strengthen our offline distribution through direct distributors in the top 50 cities. With continuous progress in this journey, our revenue for Q3FY25 stood at Rs 518 crore with 6.0% YoY growth and an EBITDA margin of 5.0%

Mamaearth continued to expand its market share and household penetration as we refine our playbooks to shape its future growth trajectory. Our emerging brands - The Derma Co., Aqualogica, BBlunt, and Dr. Sheth’s - delivered 30%+ YTD YoY growth. Additionally, our key categories (face wash, shampoo, serums, moisturizer, sun care, and baby care) saw ~18% growth in 9MFY25. We are continuing to build in these categories and aim to gain significant share in the next 3-5 year

Honasa Consumer is the largest digital-first beauty and personal care company with a diverse portfolio of six brands. Uniquely positioned to capture the growth trends shaping in the BPC market, the company is building brands through on trend data-based innovation and strong omnichannel distribution.

Powered by Capital Market - Live News

The key equity indices traded with substantial gains in the morning trade as inflation eased to a five-month low, according to data released by the government. The Nifty traded above the 23,150 mark after hitting the day's low of 22,992.20 in early trade. Pharma shares advanced after declining over the past three consecutive trading sessions. Trading could be volatile due to the weekly Nifty 50 F&O series expiry today.

At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 350.96 points or 0.46% to 76,519.26. The Nifty 50 index added 110.35 points or 0.48% to 23,155.60.

In the broader market, The S&P BSE Mid-Cap index rallied 1.10%, and the S&P BSE Small-Cap index declined 0.73%.

The market breadth was positive. On the BSE, 2,395 shares rose and 1,118 shares fell. A total of 158 shares were unchanged.

Economy:

India’s retail inflation, based on the Consumer Price Index (CPI), eased to a five-month low of 4.31% in January 2025, mainly due to lower food prices, according to official data released on Wednesday. CPI-based retail inflation was 5.22% in December, and 5.1% in January 2024.

India’s industrial production growth, measured by the Index of Industrial Production (IIP) eased to 3.2% in December, down from a 6-month high of 5.2% in the previous month, according to data released by Ministry of Statistics & Programme Implementation (MoSPI). The slowdown was largely due to weaker manufacturing activity, which grew 3% in December compared to 5.5% in November.

Result Today:

Afcons Infrastructure (down 0.84%), Allcargo Logistics (up 1.17%), Anupam Rasayan India (down 0.35%), BF Utilities (up 2.78%), Capacite Infraprojects (up 1.94%), Carborundum Universal (down 0.16%), Concord Biotech (up 2.36%), DCW (up 1.66%), Deepak Nitrite (up 1.50%), Godfrey Phillips India (down 2.58%), Goodyear India (down 2.18%), Gujarat Pipavav Port (up 0.84%), Grindwell Norton (down 0.43%), Harsha Engineers International (up 0.89%), Hindustan Construction Co (down 1.65%), HealthCare Global Enterprises (down 0.85%), Hindalco Industries (up 0.44%), IPCA Laboratories (up 2.46%), India Tourism Development (down 0.29%) will declare their results later today.

Buzzing Index:

The Nifty Pharma index jumped 1.97% to 21,558.95. The index dropped 4.23% in past three consecutive trading sessions.

Aurobindo Pharma (up 5.01%), Lupin (up 4.82%), Granules India (up 3.76%), Mankind Pharma (up 3.23%), Biocon (up 3.22%), Cipla (up 2.83%), Divis Laboratories (up 2.78%), Laurus Labs (up 2.65%), Ipca Laboratories (up 2.12%) and Glenmark Pharmaceuticals (up 1.91%) advanced.

Stocks in Spotlight:

Honasa Consumer jumped 5.01% after the company’s consolidated net profit increased marginally to Rs 26.02 crore in Q3 FY25, up 0.5% as compared with Rs 25.90 crore in Q3 FY24. Net sales rose 6% to Rs 571.51 crore in Q3 FY25 as compared with Rs 488.22 crore in Q3 FY24.

Jupiter Wagons (JWL) rose 1.31% after the company said that it has received order from Ambuja Cement and ACC for manufacture and supply of BCFCM rakes wagon and the value of these orders is Rs 600 crore.

Rites added 1.10% after the company said that it has signed a memorandum of understanding (MoU) with a Centre for Development of Advanced Computing (C-DAC) to collaborate on IT solutions for consultancy assignments.

Powered by Capital Market - Live News

Net profit of Honasa Consumer rose 0.46% to Rs 26.02 crore in the quarter ended December 2024 as against Rs 25.90 crore during the previous quarter ended December 2023. Sales rose 6.00% to Rs 517.51 crore in the quarter ended December 2024 as against Rs 488.22 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News